Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 9:43 AM UTC
| NCT Number | NCT06465329 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | July 8, 2026 (1 week ago) |
As of July 20, 2026: Clinical trial NCT06465329 is currently recruiting participants. This phase2 study for lung cancer is actively seeking new participants at 15 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06465329 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06465329 was last updated 1 week ago (July 8, 2026). HelloStudys verifies this status automatically.